Search this website. You can use fund codes to locate specific funds

Food for thought: the irresistible rise of sustainable proteins

Public Engagement Report Q3 2019

Fast reading

  • Sustainable food systems and the growth of plant-based nutrition
  • Engagement vs Divestment - which is more effective?
  • Responsible tax practices
  • Engaging on the UN Sustainable Development Goals

The Public Engagement Report highlights some of the stewardship activities undertaken by Hermes EOS on behalf of its clients over Q3 2019.

Our cover story this quarter looks at the contribution that animal livestock systems make to climate change, deforestation and biodiversity loss, and the growing demand for more sustainable proteins, including plant-based alternatives.

We also examine the campaign for fossil fuel divestment, setting out why we think engagement may prove more effective over the long term. Other articles focus on how investors can ensure companies pay an appropriate amount of tax, and ways to engage on the UN's Sustainable Development Goals.   

 

 

Related Insights

Biodiversity in focus in EOS’s Q3 Public Engagement Report
Why companies need to stop taking nature for granted
Public Engagement Report Q3 2020
The Public Engagement Report highlights some of the stewardship activities undertaken by EOS at Federated Hermes on behalf of its clients over Q3 2020.
Climate change and human rights
Climate change is not only having a devastating impact on the environment, it is also a human rights issue.
NetEase case study
NetEase published its inaugural ESG report in June 2020, covering material ESG topics including data privacy and protection, and GDPR compliance. EOS is pleased with its commitment to improve shareholder communication and continues to engage with the company on the wider ESG agenda.
HEINEKEN case study
HEINEKEN has improved the standard and transparency of its business conduct policies, increasing investor confidence. EOS continues to engage with the company on its accountability to its key values of integrity and fairness and on other ESG issues.
Takeda Pharmaceutical case study
Takeda Pharmaceutical has significantly improved the transparency and accountability of its executive remuneration, aligning itself more closely to global peers. EOS has engaged it on this topic for the past 16 months to increase investor confidence in the company for the long term.

EOS Client Service and Business Development

Amy D’Eugenio,
Head of Client Service and Business Development, EOS